The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

Delfi Diagnostics is combining AI and liquid biopsy tech to make routine blood tests a powerful tool against cancer —starting ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

Q1 2025 Management View Jeff Hawkins, President and CEO, highlighted three corporate priorities: accelerating commercial ...